Histone Deacetylase Inhibitors: From Bench to Clinic - ACS Publications

Discovery of (2E)-3-{2-Butyl-1-[2-(diethylamino)ethyl]-1H-benzimidazol-5-yl}-N-hydroxyacrylamide (SB939), an Orally Active Histone Deacetylase Inhibit...
0 downloads 0 Views 18KB Size
3330

J. Med. Chem. 2008, 51, 3330

Additions and Corrections

2008, Volume 51

Marielle Paris, Marina Porcelloni, Monica Binaschi, and Daniela Fattori*: Histone Deacetylase Inhibitors: From Bench to Clinic. Page 1506. In Figure 1, the structure given for compound 1l (SB-939) is incorrect. The correct structure for this compound is shown below.

JM800398R 10.1021/jm800398r Published on Web 05/15/2008